Keywords
Last Name
Institution

Barbara H. McGovern

TitleAssociate Professor
InstitutionLemuel Shattuck Hospital
DepartmentMedicine
AddressDivision of Infectious Disease
Lemuel Shattuck Hospital
170 Morton Street, Outpatient Clinic 1st Floor
Boston MA 02130
Phone(781) 392-2419
Fax(617) 971-3853
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Badri PS, King JR, Polepally AR, McGovern BH, Dutta S, Menon RM. Dosing Recommendations for Concomitant Medications During 3D Anti-HCV Therapy. Clin Pharmacokinet. 2016 Mar; 55(3):275-95. PMID: 26330025.
      View in: PubMed
    2. Page K, Mirzazadeh A, Rice TM, Grebely J, Kim AY, Cox AL, Morris MD, Hellard M, Bruneau J, Shoukry NH, Dore GJ, Maher L, Lloyd AR, Lauer G, Prins M, McGovern BH. Interferon Lambda 4 Genotype Is Associated With Jaundice and Elevated Aminotransferase Levels During Acute Hepatitis C Virus Infection: Findings From the InC3 Collaborative. Open Forum Infect Dis. 2016 Jan; 3(1):ofw024. PMID: 26973850.
      View in: PubMed
    3. Khanna S, Pardi DS, Kelly CR, Kraft CS, Dhere T, Henn MR, Lombardo MJ, Vulic M, Ohsumi T, Winkler J, Pindar C, McGovern BH, Pomerantz RJ, Aunins JG, Cook DN, Hohmann EL. A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection. J Infect Dis. 2016 Jul 15; 214(2):173-81. PMID: 26908752.
      View in: PubMed
    4. Onofrey S, Aneja J, Haney GA, Nagami EH, DeMaria A, Lauer GM, Hills-Evans K, Barton K, Kulaga S, Bowen MJ, Cocoros N, McGovern BH, Church DR, Kim AY. Underascertainment of Acute Hepatitis C Virus Infections in the U.S. Surveillance System: A Case Series and Chart Review. Ann Intern Med. 2015 Aug 18; 163(4):254-61. PMID: 26121304.
      View in: PubMed
    5. Doyle JS, Deterding K, Grebely J, Wedemeyer H, Sacks-Davis R, Spelman T, Matthews G, Rice TM, Morris MD, McGovern BH, Kim AY, Bruneau J, Lloyd AR, Page K, Manns MP, Hellard ME, Dore GJ. Response to treatment following recently acquired hepatitis C virus infection in a multicentre collaborative cohort. J Viral Hepat. 2015 Dec; 22(12):1020-32. PMID: 26098993.
      View in: PubMed
    6. Sacks-Davis R, Grebely J, Dore GJ, Osburn W, Cox AL, Rice TM, Spelman T, Bruneau J, Prins M, Kim AY, McGovern BH, Shoukry NH, Schinkel J, Allen TM, Morris M, Hajarizadeh B, Maher L, Lloyd AR, Page K, Hellard M. Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection-the InC3 Study. J Infect Dis. 2015 Nov 1; 212(9):1407-19. PMID: 25883387.
      View in: PubMed
    7. Hajarizadeh B, Grady B, Page K, Kim AY, McGovern BH, Cox AL, Rice TM, Sacks-Davis R, Bruneau J, Morris M, Amin J, Schinkel J, Applegate T, Maher L, Hellard M, Lloyd AR, Prins M, Dore GJ, Grebely J. Patterns of Hepatitis C Virus RNA Levels during Acute Infection: The InC3 Study. PLoS One. 2015; 10(4):e0122232. PMID: 25837807.
      View in: PubMed
    8. Lalezari J, Sullivan JG, Varunok P, Galen E, Kowdley KV, Rustgi V, Aguilar H, Felizarta F, McGovern B, King M, Polepally AR, Cohen DE. Ombitasvir/paritaprevir/r and dasabuvir plus ribavirin in HCV genotype 1-infected patients on methadone or buprenorphine. J Hepatol. 2015 Aug; 63(2):364-9. PMID: 25839406.
      View in: PubMed
    9. Sulkowski MS, Eron JJ, Wyles D, Trinh R, Lalezari J, Wang C, Slim J, Bhatti L, Gathe J, Ruane PJ, Elion R, Bredeek F, Brennan R, Blick G, Khatri A, Gibbons K, Hu YB, Fredrick L, Schnell G, Pilot-Matias T, Tripathi R, Da Silva-Tillmann B, McGovern B, Campbell AL, Podsadecki T. Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial. JAMA. 2015 Mar 24-31; 313(12):1223-31. PMID: 25706092.
      View in: PubMed
    10. Hajarizadeh B, Grady B, Page K, Kim AY, McGovern BH, Cox AL, Rice TM, Sacks-Davis R, Bruneau J, Morris M, Amin J, Schinkel J, Applegate T, Maher L, Hellard M, Lloyd AR, Prins M, Geskus RB, Dore GJ, Grebely J. Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC(3) study. J Viral Hepat. 2015 Sep; 22(9):708-17. PMID: 25580520.
      View in: PubMed
    11. Hajarizadeh B, Grady B, Page K, Kim AY, McGovern BH, Cox AL, Rice TM, Sacks-Davis R, Bruneau J, Morris M, Amin J, Schinkel J, Applegate T, Maher L, Hellard M, Lloyd AR, Prins M, Geskus RB, Dore GJ, Grebely J. Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: The InC(3) Study. J Clin Virol. 2014 Nov; 61(3):430-4. PMID: 25256151.
      View in: PubMed
    12. Grebely J, Page K, Sacks-Davis R, van der Loeff MS, Rice TM, Bruneau J, Morris MD, Hajarizadeh B, Amin J, Cox AL, Kim AY, McGovern BH, Schinkel J, George J, Shoukry NH, Lauer GM, Maher L, Lloyd AR, Hellard M, Dore GJ, Prins M. The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology. 2014 Jan; 59(1):109-20. PMID: 23908124; NIHMSID: NIHMS562465 [Available on 01/01/15].
      View in: PubMed
    13. Kim AY, Nagami EH, Birch CE, Bowen MJ, Lauer GM, McGovern BH. A simple strategy to identify acute hepatitis C virus infection among newly incarcerated injection drug users. Hepatology. 2013 Mar; 57(3):944-52. PMID: 23111904; NIHMSID: NIHMS485579.
      View in: PubMed
    14. Spaulding AS, Kim AY, Harzke AJ, Sullivan JC, Linas BP, Brewer A, Dickert J, McGovern BH, Strick LB, Trestman R, Ferguson WJ. Impact of new therapeutics for hepatitis C virus infection in incarcerated populations. Top Antivir Med. 2013 Feb-Mar; 21(1):27-35. PMID: 23596276; NIHMSID: NIHMS539126.
      View in: PubMed
    15. McGovern BH. Care of the patient with hepatitis C virus infection. Preface. Infect Dis Clin North Am. 2012 Dec; 26(4):xi-xii. PMID: 23083830.
      View in: PubMed
    16. Grebely J, Morris MD, Rice TM, Bruneau J, Cox AL, Kim AY, McGovern BH, Shoukry NH, Lauer G, Maher L, Lloyd AR, Hellard M, Prins M, Dore GJ, Page K. Cohort profile: the international collaboration of incident HIV and hepatitis C in injecting cohorts (InC3) study. Int J Epidemiol. 2013 Dec; 42(6):1649-59. PMID: 23203695; PMCID: PMC3887561 [Available on 12/01/14].
      View in: PubMed
      View in: PubMed Central
    17. Nagami EH, Kim AY, Baden RP, McGovern BH. Syphilis negatively influences the response to hepatitis C virus treatment in an HIV-infected patient. Top Antivir Med. 2012 Oct-Nov; 20(4):134-8. PMID: 23154253; NIHMSID: NIHMS506234.
      View in: PubMed
    18. McGovern BH. Editorial commentary: Hepatitis C virus and the infectious disease physician: a perfect match. Clin Infect Dis. 2012 Aug; 55(3):414-7. PMID: 22491341.
      View in: PubMed
    19. Schulze Zur Wiesch J, Ciuffreda D, Lewis-Ximenez L, Kasprowicz V, Nolan BE, Streeck H, Aneja J, Reyor LL, Allen TM, Lohse AW, McGovern B, Chung RT, Kwok WW, Kim AY, Lauer GM. Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence. J Exp Med. 2012 Jan 16; 209(1):61-75. PMID: 22213804; PMCID: PMC3260872.
      View in: PubMed
      View in: PubMed Central
    20. Forrester JE, Rhee MS, McGovern BH, Sterling RK, Knox TA, Terrin N. The association of HIV viral load with indirect markers of liver injury. J Viral Hepat. 2012 Feb; 19(2):e202-11. PMID: 22239520; NIHMSID: NIHMS319337.
      View in: PubMed
    21. McGovern BH. Hepatic steatosis in HIV/HCV-coinfected patients: time to reevaluate! Gastroenterology. 2011 Mar; 140(3):772-5. PMID: 21276415.
      View in: PubMed
    22. Nagami EH, Kim AY, Birch CE, Bowen MJ, McGovern BH. A "one-two punch" leading to hepatitis C seroconversion. Clin Infect Dis. 2011 Feb 1; 52(3):361-3. PMID: 21189425; PMCID: PMC3060887.
      View in: PubMed
      View in: PubMed Central
    23. Taylor LE, Bowman SE, Chapman S, Zaller N, Stein MD, Cioe PA, Maynard MA, McGovern BH. Treatment for hepatitis C virus genotype 1 infection in HIV-infected individuals on methadone maintenance therapy. Drug Alcohol Depend. 2011 Jul 1; 116(1-3):233-7. PMID: 21177046; NIHMSID: NIHMS374548.
      View in: PubMed
    24. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science. 2010 Dec 10; 330(6010):1551-7. PMID: 21051598; NIHMSID: NIHMS331514.
      View in: PubMed
    25. McGovern BH, Birch CE, Bowen MJ, Reyor LL, Nagami EH, Chung RT, Kim AY. Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteria. Clin Infect Dis. 2009 Oct 1; 49(7):1051-60. PMID: 19725787; NIHMSID: NIHMS118424.
      View in: PubMed
    26. McGovern BH, Nagami EH, Birch CE, Bowen MJ, Reyor LL, Chung RT, Kim AY. Rate of sustained virologic response in relation to baseline hepatitis C virus (HCV) RNA level and rapid virologic clearance in persons with acute HCV infection. J Infect Dis. 2009 Sep 15; 200(6):877-81. PMID: 19673649; NIHMSID: NIHMS111794.
      View in: PubMed
    27. Forrester JE, McGovern BH, Rhee MS, Sterling RK. The individual and combined influence of HIV and hepatitis C virus on dyslipidaemia in a high-risk Hispanic population. HIV Med. 2009 Oct; 10(9):555-63. PMID: 19496835; NIHMSID: NIHMS149344.
      View in: PubMed
    28. McGovern B, Kim A, Lauer G. Acute hepatitis C infection in correctional settings. Gastroenterology. 2009 Jun; 136(7):2410-1. PMID: 19409289.
      View in: PubMed
    29. McGovern BH, Abu Dayyeh BK, Chung RT. Avoiding therapeutic pitfalls: the rational use of specifically targeted agents against hepatitis C infection. Hepatology. 2008 Nov; 48(5):1700-12. PMID: 18972443.
      View in: PubMed
    30. Soriano V, Puoti M, Garcia-Gascó P, Rockstroh JK, Benhamou Y, Barreiro P, McGovern B. Antiretroviral drugs and liver injury. AIDS. 2008 Jan 2; 22(1):1-13. PMID: 18090386.
      View in: PubMed
    31. McGovern B. A golden opportunity: the treatment of hepatitis C in HIV-infected inmates. J Addict Dis. 2008; 27(2):69-73. PMID: 18681193.
      View in: PubMed
    32. McGovern BH, Birch C, Zaman MT, Bica I, Stone D, Quirk JR, Davis B, Zachary K, Basgoz N, Graeme-Cook F, Gandhi RT. Managing symptomatic drug-induced liver injury in HIV-hepatitis C virus-coinfected patients: a role for interferon. Clin Infect Dis. 2007 Nov 15; 45(10):1386-92. PMID: 17968840.
      View in: PubMed
    33. McGovern BH. Hepatitis C in the HIV-infected patient. J Acquir Immune Defic Syndr. 2007 Jul 1; 45 Suppl 2:S47-56; discussion S66-7. PMID: 17704692.
      View in: PubMed
    34. McGovern B. Antiretroviral therapy for patients with HIV-hepatitis B virus coinfection. Clin Infect Dis. 2007 Apr 1; 44(7):1012-3; author reply 1013. PMID: 17342661.
      View in: PubMed
    35. McGovern BH. The epidemiology, natural history and prevention of hepatitis B: implications of HIV coinfection. Antivir Ther. 2007; 12 Suppl 3:H3-13. PMID: 18284178.
      View in: PubMed
    36. McGovern BH, Golan Y, Lopez M, Pratt D, Lawton A, Moore G, Epstein M, Knox TA. The impact of cirrhosis on CD4+ T cell counts in HIV-seronegative patients. Clin Infect Dis. 2007 Feb 1; 44(3):431-7. PMID: 17205454.
      View in: PubMed
    37. McGovern BH, Ditelberg JS, Taylor LE, Gandhi RT, Christopoulos KA, Chapman S, Schwartzapfel B, Rindler E, Fiorino AM, Zaman MT, Sax PE, Graeme-Cook F, Hibberd PL. Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients. Clin Infect Dis. 2006 Aug 1; 43(3):365-72. PMID: 16804853.
      View in: PubMed
    38. Rubin D, McGovern B, Kopelman RI. Back to basics. Am J Med. 2006 Jun; 119(6):482-3. PMID: 16750959.
      View in: PubMed
    39. McGovern BH, Wurcel A, Kim AY, Schulze zur Wiesch J, Bica I, Zaman MT, Timm J, Walker BD, Lauer GM. Acute hepatitis C virus infection in incarcerated injection drug users. Clin Infect Dis. 2006 Jun 15; 42(12):1663-70. PMID: 16705568.
      View in: PubMed
    40. Schulze zur Wiesch J, Lauer GM, Day CL, Kim AY, Ouchi K, Duncan JE, Wurcel AG, Timm J, Jones AM, Mothe B, Allen TM, McGovern B, Lewis-Ximenez L, Sidney J, Sette A, Chung RT, Walker BD. Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes. J Immunol. 2005 Sep 15; 175(6):3603-13. PMID: 16148104.
      View in: PubMed
    41. McGovern B, Fiore J, Wurcel A, Taglienti P, Bradley M, Galvin S, Libone G, Ramsey J, Molinaro-Gudas V, Drewniak S, Amick C, Andalkar A, Scheft H, Bica I. Delivering therapy for hepatitis C virus infection to incarcerated HIV-seropositive patients. Clin Infect Dis. 2005 Jul 1; 41 Suppl 1:S56-62. PMID: 16265615.
      View in: PubMed
    42. Gandhi RT, Wurcel A, Lee H, McGovern B, Shopis J, Geary M, Sivamurthy R, Sax PE, Ukomadu C. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies. J Infect Dis. 2005 May 1; 191(9):1435-41. PMID: 15809901.
      View in: PubMed
    43. McGovern B. Hepatic safety and HAART. J Int Assoc Physicians AIDS Care (Chic). 2004 Nov; 3 Suppl 2:S24-40. PMID: 15673131.
      View in: PubMed
    44. McGovern B. What drives hepatitis B virus-related hepatic flares? Virus, T cells--or a bit of both? Clin Infect Dis. 2004 Jul 1; 39(1):133-5. PMID: 15206065.
      View in: PubMed
    45. Silbernagel K, Jechorek R, Barbour WM, Mrozinski P, Alejo W, Aleo V, Andaloro B, Beacorn F, Benzinger J, Bogar S, Brayman C, Broom J, Carson M, Carver C, Cheng C, Centrella B, Clayborn J, Collins C, Deibel C, Divine M, Eliasberg S, Farmer D, Frye S, Gatesy T, Goodstein E, Halker C, Hall G, Hanson P, Hartman G, Heddaeus K, Hembree J, Hutchins J, Istafanos P, Jechorek R, Jenkins J, Kerdahi K, Kremer S, Lal A, Leighton S, Lester D, Lewis J, Lin J, Martin J, Maselli M, McCarthy P, McGovern B, Mills M, Mohnke F, Moon B, Moss D, Plaza M, Robeson S, Romero H, Rubalcaba D, Schultz A, Seehusen J, Shaw C, Siem K, Sloan E, Stanerson J, Stepanova N, Van K, Van Enkenvoort K, Vialpando M, Warren W, Watts K, Wilson K, Woodruff T. Evaluation of the BAX system for detection of Listeria monocytogenes in foods: collaborative study. J AOAC Int. 2004 Mar-Apr; 87(2):395-410. PMID: 15164834.
      View in: PubMed
    46. Gandhi RT, Wurcel A, McGovern B, Lee H, Shopis J, Corcoran CP, Toner S, Giachetti C, Dockter J, Sax PE, Ukomadu C. Low prevalence of ongoing hepatitis B viremia in HIV-positive individuals with isolated antibody to hepatitis B core antigen. J Acquir Immune Defic Syndr. 2003 Dec 1; 34(4):439-41. PMID: 14615664.
      View in: PubMed
    47. McGovern B, Bica I. Should treatment of hepatitis C in HIV-seropositive and HIV-seronegative patients with hemophilia include induction doses of interferon? Clin Infect Dis. 2003 Aug 1; 37(3):463-4; author reply 464-5. PMID: 12884180.
      View in: PubMed
    48. Gandhi RT, Wurcel A, Lee H, McGovern B, Boczanowski M, Gerwin R, Corcoran CP, Szczepiorkowski Z, Toner S, Cohen DE, Sax PE, Ukomadu C. Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals. Clin Infect Dis. 2003 Jun 15; 36(12):1602-5. PMID: 12802762.
      View in: PubMed
    49. Day CL, Lauer GM, Robbins GK, McGovern B, Wurcel AG, Gandhi RT, Chung RT, Walker BD. Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection. J Virol. 2002 Dec; 76(24):12584-95. PMID: 12438584; PMCID: PMC136690.
      View in: PubMed
      View in: PubMed Central
    50. Stone DR, Corcoran C, Wurcel A, McGovern B, Quirk J, Brewer A, Sutton L, D'Aquila RT. Antiretroviral drug resistance mutations in antiretroviral-naive prisoners. Clin Infect Dis. 2002 Oct 1; 35(7):883-6. PMID: 12228827.
      View in: PubMed
    51. McGovern B. Evaluation and treatment of the HIV/HCV coinfected patient: a case history and discussion. AIDS Patient Care STDS. 2002 Jul; 16(7):319-26. PMID: 12194729.
      View in: PubMed
    52. McGovern B, Bica I. Risk of HAART therapy in hepatitis C. Hepatology. 2002 Mar; 35(3):730. PMID: 11870393.
      View in: PubMed
    53. Tanios MA, Kogelman L, McGovern B, Hassoun PM. Acute respiratory distress syndrome complicating Plasmodium vivax malaria. Crit Care Med. 2001 Mar; 29(3):665-7. PMID: 11373440.
      View in: PubMed
    54. Bica I, McGovern B, Dhar R, Stone D, McGowan K, Scheib R, Snydman DR. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis. 2001 Feb 1; 32(3):492-7. PMID: 11170959.
      View in: PubMed
    55. Chow T, Galvin J, McGovern B. Antiarrhythmic drug therapy in patients with renal failure, liver failure, and congestive heart failure. Heart Dis. 1999 May-Jun; 1(2):98-107. PMID: 11720610.
      View in: PubMed
    56. Chow T, Galvin J, McGovern B. Antiarrhythmic drug therapy in pregnancy and lactation. Am J Cardiol. 1998 Aug 20; 82(4A):58I-62I. PMID: 9737655.
      View in: PubMed
    57. Krishnan SC, Galvin J, McGovern B, Garan H, Ruskin JN. Reproducible induction of "atypical" torsades de pointes by programmed electrical stimulation: a novel form of sotalol-induced proarrhythmia? J Cardiovasc Electrophysiol. 1997 Sep; 8(9):1055-61. PMID: 9300303.
      View in: PubMed
    58. Nunain SO, Roelke M, Trouton T, Osswald S, Kim YH, Sosa-Suarez G, Brooks DR, McGovern B, Guy M, Torchiana DF, et al. Limitations and late complications of third-generation automatic cardioverter-defibrillators. Circulation. 1995 Apr 15; 91(8):2204-13. PMID: 7697850.
      View in: PubMed
    59. DiMarco JP, Miles W, Akhtar M, Milstein S, Sharma AD, Platia E, McGovern B, Scheinman MM, Govier WC. Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group. Ann Intern Med. 1990 Jul 15; 113(2):104-10. PMID: 2193560.
      View in: PubMed
    60. Thomas GS, Garan H, Davis MJ, Curfman GD, Dec GW, Boucher CA, Slater WR, McGovern B, Ruskin JN. Exercise electrophysiology testing: the effect of exercise on the induction of ventricular arrhythmias by programmed ventricular stimulation. Pacing Clin Electrophysiol. 1990 Jan; 13(1):17-22. PMID: 1689029.
      View in: PubMed
    61. Whitford EG, McGovern B, Schoenfeld MH, Garan H, Newell JB, McElroy M, Ruskin JN. Long-term efficacy of mexiletine alone and in combination with class Ia antiarrhythmic drugs for refractory ventricular arrhythmias. Am Heart J. 1988 Feb; 115(2):360-6. PMID: 3341170.
      View in: PubMed
    62. Wilber DJ, Garan H, Finkelstein D, Kelly E, Newell J, McGovern B, Ruskin JN. Out-of-hospital cardiac arrest. Use of electrophysiologic testing in the prediction of long-term outcome. N Engl J Med. 1988 Jan 7; 318(1):19-24. PMID: 3336381.
      View in: PubMed
    63. McGovern B, Garan H, Ruskin JN. Precipitation of cardiac arrest by verapamil in patients with Wolff-Parkinson-White syndrome. Ann Intern Med. 1986 Jun; 104(6):791-4. PMID: 3706931.
      View in: PubMed
    64. McGovern B, Geer VR, LaRaia PJ, Garan H, Ruskin JN. Possible interaction between amiodarone and phenytoin. Ann Intern Med. 1984 Nov; 101(5):650-1. PMID: 6486598.
      View in: PubMed
    65. McGovern B, Garan H, Ruskin JN. Treatment of ventricular arrhythmias--suppression, survival, and the problem of bias. Ann Intern Med. 1984 Jul; 101(1):123-5. PMID: 6375500.
      View in: PubMed
    McGovern's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _
    This website was supported by the National Center for Research Resources Award Number UL1RR025752 and the National Center for Advancing Translational Sciences, National Institutes of Health, Award Numbers UL1TR000073 and UL1TR001064. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

    Disclaimer | Tufts University | Tufts CTSI 2015